Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Series A

CFS fuses $84m with series A2
MIT's fusion energy spinout Commonwealth Fusion Systems secured the return of The Engine and Eni for a $84m series A2 round that followed a $115m series A last year.
Statespace locks in $15m
NYU-founded cognitive skills building software developer Statespace secured investors including Khosla Ventures to bring its overall funding to $19m.
Daily deal net: May 26, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Daily deal net: May 22, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Octant circles $30m series A
Led by UCLA’s Sri Kosuri, Octant is working on drugs for complex diseases and will use the series A funding to further develop its platform.
Navenio navigates $11m series A
OSI has returned to back Oxford indoor mapping spinout Navenio as the latter expands the market for its hospital workforce allocation system.
Quralis curates $42m series A
The Harvard motor neurone disease drug developer secured the return of Amgen Ventures for its series A round.
Kriya kicks off $80.5m series A proceedings
Dexcel Pharma formed part of a consortium that has supplied $80.5m in series A financing to Kriya Therapeutics, a gene therapy developer exploiting Stanford University research.

Other News

Daily deal net: May 7, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Ventus tears into $60m series A
GV has invested in Ventus Therapeutics, an immunotherapy developer co-founded by faculty from multiple academic institutions.
Daily deal net: May 4, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Genespire generates $17.6m
San Raffaele-Telethon gene therapy spinout Genespire has picked up series A funding from Sofinnova Partners to target inherited metabolic diseases and primary immunodeficiencies.
Actym Therapeutics actions $34m
Boehringer Ingelheim Venture Fund co-led a series A round set to drive clinical work on UC Berkeley-founded Actym Therapeutics' immunotherapy pipeline.
LifeSprout bolts on series A funding
JHU-founded restorative materials technology developer Lifesprout secured $28.5m in a round led by Redmile Group as it looks to move into regenerative medicine.

Editor's Picks

Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Big deal: NMD flexes series A muscles
Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.
Immunocore smashes European biotech records
Immunotherapy firm Immunocore, which started life at Oxford University, raises the largest biotech round in European history.
Sphere Fluidics circles $2.5m
test reg

Login